These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 2447689)

  • 21. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
    Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
    Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Donor-specific tolerance by perioperative intrathymic injection of bone marrow cells in the rat cardiac allograft model: use of FK506 can shorten the necessary duration of pretransplant intrathymic conditioning.
    Ito A; Ito T; Kamiike W; Moriguchi A; Ohkawa A; Uchikoshi F; Tanaka S; Nakata S; Matsuda H
    Transplantation; 1997 Sep; 64(5):752-7. PubMed ID: 9311715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological unresponsiveness to hepatic allografts in rats. Immunological reactivities of the recipient to donor antigens.
    Hasuike Y; Monden M; Valdivia LA; Kubota N; Nakano Y; Gotoh M; Okamura J; Mori T
    Transplantation; 1989 Jun; 47(6):1043-7. PubMed ID: 2660342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of combination treatment with FK506 and cyclosporine on survival time and vascular changes in renal-allograft-recipient dogs.
    Ochiai T; Sakamoto K; Gunji Y; Hamaguchi K; Isegawa N; Suzuki T; Shimada H; Hayashi H; Yasumoto A; Asano T
    Transplantation; 1989 Aug; 48(2):193-7. PubMed ID: 2474209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limb allografts in rats immunosuppressed with FK506. I. Reversal of rejection and indefinite survival.
    Arai K; Hotokebuchi T; Miyahara H; Arita C; Mohtai M; Sugioka Y; Kaibara N
    Transplantation; 1989 Nov; 48(5):782-6. PubMed ID: 2479130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
    Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
    J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral donor leukocytes prolong survival of rat renal allografts.
    Noris M; Azzollini N; Mister M; Pezzotta A; Piccinini G; Casiraghi F; Cugini D; Perico N; Orisio S; Remuzzi G
    Kidney Int; 1999 Sep; 56(3):1101-12. PubMed ID: 10469380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of donor-specific immunoregulatory T-cells after local CTLA4Ig gene transfer to pancreatic allograft.
    Miao G; Ito T; Uchikoshi F; Akamaru Y; Kiyomoto T; Komodo H; Song J; Nozawa M; Matsuda H
    Transplantation; 2004 Jul; 78(1):59-64. PubMed ID: 15257039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Permanent rat cardiac allograft survival induced by ultraviolet B-irradiated donor lymphocytes and peritransplant cyclosporine.
    Oluwole SF; Fawwaz RA; Reemtsma K; Hardy MA
    Surgery; 1988 Aug; 104(2):231-8. PubMed ID: 2969630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporine and experimental skin allografts. II. Indefinite survival and development of specific immunologic unresponsiveness.
    Towpik E; Kupiec-Weglinski JW; Schneider TM; Tyler D; Padberg W; Araneda D; Tilney NL
    Transplantation; 1985 Dec; 40(6):714-8. PubMed ID: 3907046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance.
    Chavin KD; Qin L; Woodward JE; Lin J; Bromberg JS
    Transplantation; 1994 Mar; 57(5):736-40. PubMed ID: 7511258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged limb allograft survival with short-term treatment with FK-506 in rats.
    Arai K; Hotokebuchi T; Miyahara H; Arita C; Mohtai M; Sugioka Y; Kaibara N
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3191-3. PubMed ID: 2468256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavior of helper T lymphocytes in cyclosporine-mediated long-term graft acceptance in the rat.
    Kupiec-Weglinski JW; Heidecke CD; Araujo JL; Abbud-Filho M; Towpik E; Araneda D; Strom TB; Tilney NL
    Cell Immunol; 1985 Jun; 93(1):168-77. PubMed ID: 3158407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerance in a rat cardiac allograft model after short-term treatment with LF 08-0299. Absence of clonal deletion and evidence of CD4+ suppressor cells.
    Andoins C; de Fornel D; Annat J; Dutartre P
    Transplantation; 1996 Dec; 62(11):1543-9. PubMed ID: 8970605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late adjunctive therapy with single doses of rapamycin in skin-allografted mice treated with antilymphocyte serum and donor bone marrow cells.
    De Fazio SR; Plowey JM; Hartner WC; Gozzo JJ
    Transpl Immunol; 1996 Jun; 4(2):105-12. PubMed ID: 8843586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 15AU81, a prostacyclin analog, enhances donor-specific hepatocytes to prolong the survival of rat heart but not small bowel allografts.
    Boyle MJ; Dumble LJ
    Cell Transplant; 1999; 8(5):543-8. PubMed ID: 10580348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that indefinite survival of small bowel allografts achieved by a brief course of cyclosporine or FK506 is not due to systemic hyporesponsiveness.
    Langrehr JM; Hoffman RA; Demetris AJ; Lee KK; Neuhaus P; Wren SM; Ildstad ST; Schraut WH
    Transplantation; 1992 Sep; 54(3):505-10. PubMed ID: 1384185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.